Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Advances in Clinical Cardiology 2018: A Summary of Key Clinical Trials.

Linden K, McQuillan C, Brennan P, Menown IBA.

Adv Ther. 2019 Jul;36(7):1549-1573. doi: 10.1007/s12325-019-00962-1. Epub 2019 May 7. Review.

PMID:
31065993
2.

Cardiology and Therapy: A Summary of 2018 and Key Areas of Emerging Research in 2019.

Menown IBA, Giugliano RP, Zeymer U.

Cardiol Ther. 2019 Jun;8(1):1-3. doi: 10.1007/s40119-019-0125-6. Epub 2019 Jan 25. No abstract available.

3.

Three-year clinical outcomes after dual-therapy COMBO stent placement: Insights from the REMEDEE registry.

Kalkman DN, Kerkmeijer LS, Woudstra P, Menown IBA, Suryapranata H, den Heijer P, Iñiguez A, van 't Hof AWJ, Erglis A, Arkenbout KE, Muller P, Koch KT, Tijssen JG, Beijk MAM, de Winter RJ.

Catheter Cardiovasc Interv. 2018 Dec 18. doi: 10.1002/ccd.28047. [Epub ahead of print]

PMID:
30565371
4.

Advances in Clinical Cardiology 2017: A Summary of Key Clinical Trials.

McQuillan C, Gray A, Kearney A, Menown IBA.

Adv Ther. 2018 Jul;35(7):899-927. doi: 10.1007/s12325-018-0716-y. Epub 2018 Jun 14. Review.

PMID:
29949039
5.

Early discontinuation of dual antiplatelet therapy in patients treated with the bio-engineered pro-healing sirolimus-eluting (COMBO) stent.

Kalkman DN, Woudstra P, Menown IBA, Tijssen JG, Beijk MAM, de Winter RJ; REMEDEE Registry collaborators.

Cardiovasc Revasc Med. 2018 Apr - May;19(3 Pt B):373-375. doi: 10.1016/j.carrev.2017.10.005. Epub 2017 Oct 17.

PMID:
29277288
6.

Two-year clinical outcomes of patients treated with the dual-therapy stent in a 1000 patient all-comers registry.

Kalkman DN, Woudstra P, Menown IBA, den Heijer P, Van't Hof AW, Erglis A, Suryapranata H, Arkenbout KE, Iñiguez A, Muller P, Tijssen JG, Beijk MAM, de Winter RJ.

Open Heart. 2017 Jul 11;4(2):e000634. doi: 10.1136/openhrt-2017-000634. eCollection 2017.

7.

Advances in Clinical Cardiology 2016: A Summary of the Key Clinical Trials.

Gray A, McQuillan C, Menown IBA.

Adv Ther. 2017 Jul;34(7):1503-1527. doi: 10.1007/s12325-017-0560-5. Epub 2017 May 23. Review.

8.

Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome.

Kalkman DN, Woudstra P, Lu H, Menown IBA, den Heijer P, Suryapranata H, Iñiguez A, Arkenbout KE, Van't Hof AWJ, Muller P, Erglis A, Tijssen JG, Beijk MAM, de Winter RJ.

Catheter Cardiovasc Interv. 2017 Aug 1;90(2):E31-E37. doi: 10.1002/ccd.26915. Epub 2017 Feb 1.

PMID:
28145609
9.

Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.

Mäkikallio T, Holm NR, Lindsay M, Spence MS, Erglis A, Menown IB, Trovik T, Eskola M, Romppanen H, Kellerth T, Ravkilde J, Jensen LO, Kalinauskas G, Linder RB, Pentikainen M, Hervold A, Banning A, Zaman A, Cotton J, Eriksen E, Margus S, Sørensen HT, Nielsen PH, Niemelä M, Kervinen K, Lassen JF, Maeng M, Oldroyd K, Berg G, Walsh SJ, Hanratty CG, Kumsars I, Stradins P, Steigen TK, Fröbert O, Graham AN, Endresen PC, Corbascio M, Kajander O, Trivedi U, Hartikainen J, Anttila V, Hildick-Smith D, Thuesen L, Christiansen EH; NOBLE study investigators.

Lancet. 2016 Dec 3;388(10061):2743-2752. doi: 10.1016/S0140-6736(16)32052-9. Epub 2016 Oct 31. Erratum in: Lancet. 2016 Dec 3;388(10061):2742.

PMID:
27810312
10.

2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents.

Garot P, Morice MC, Tresukosol D, Pocock SJ, Meredith IT, Abizaid A, Carrié D, Naber C, Iñiguez A, Talwar S, Menown IBA, Christiansen EH, Gregson J, Copt S, Hovasse T, Lurz P, Maillard L, Krackhardt F, Ong P, Byrne J, Redwood S, Windhövel U, Greene S, Stoll HP, Urban P; LEADERS FREE Investigators.

J Am Coll Cardiol. 2017 Jan 17;69(2):162-171. doi: 10.1016/j.jacc.2016.10.009. Epub 2016 Oct 30.

11.

One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stent.

Kalkman DN, Woudstra P, den Heijer P, Menown IB, Erglis A, Suryapranata H, Arkenbout KE, Iñiguez A, van 't Hof AW, Muller P, Tijssen JG, de Winter RJ.

Int J Cardiol. 2017 Jan 1;226:60-64. doi: 10.1016/j.ijcard.2016.10.032. Epub 2016 Oct 17.

12.

A Review of the Key Clinical Trials of 2015: Results and Implications.

McCune C, McKavanagh P, Menown IB.

Cardiol Ther. 2016 Dec;5(2):109-132. Epub 2016 Jun 8. Review.

13.

1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry.

Woudstra P, Kalkman DN, den Heijer P, Menown IB, Erglis A, Suryapranata H, Arkenbout KE, Iñiguez A, van 't Hof AW, Muller P, Tijssen JG, de Winter RJ.

JACC Cardiovasc Interv. 2016 Jun 13;9(11):1127-34. doi: 10.1016/j.jcin.2016.02.052. Epub 2016 May 18.

14.

Simplifying the audit of risk factor recording and control: A report from an international study in 11 countries.

Zhao M, Cooney MT, Klipstein-Grobusch K, Vaartjes I, De Bacquer D, De Sutter J, Reiner Ž, Prescott E, Faggiano P, Vanuzzo D, AlFaleh H, Menown IB, Gait D, Posogova N, Sheu WH, Zhao D, Zuo H, Grobbee DE, Graham IM.

Eur J Prev Cardiol. 2016 Jul;23(11):1202-10. doi: 10.1177/2047487316647827. Epub 2016 Apr 26.

PMID:
27118362
15.

A Review of Current Diagnosis, Investigation, and Management of Acute Coronary Syndromes in Elderly Patients.

McCune C, McKavanagh P, Menown IB.

Cardiol Ther. 2015 Dec;4(2):95-116. doi: 10.1007/s40119-015-0047-x. Epub 2015 Sep 22.

16.

Anomalous Left Main Coronary Artery: Not Always a Simple Surgical Reimplantation.

Khan AH, Menown IB, Graham A, Purvis JA.

Cardiol Ther. 2015 Jun;4(1):77-82. doi: 10.1007/s40119-015-0039-x. Epub 2015 May 5.

17.

A Review of the Key Clinical Trials of 2014.

McKavanagh P, McCune C, Menown IB.

Cardiol Ther. 2015 Jun;4(1):5-23. doi: 10.1007/s40119-015-0036-0. Epub 2015 Mar 27.

18.

One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE).

Tamburino C, Capodanno D, Erglis A, Menown IB, Horváth IG, Moreno R, Gilbert TJ, Crowley JJ, Calabria P, Allocco DJ, Dawkins KD.

EuroIntervention. 2015 Mar;10(11):1261-6. doi: 10.4244/EIJY15M01_01.

19.

Advances in clinical cardiology.

McNeice AH, McAleavey NM, Menown IB.

Adv Ther. 2014 Aug;31(8):837-60. doi: 10.1007/s12325-014-0141-9. Epub 2014 Jul 30. Review.

PMID:
25074280
20.

2013: The year of renal denervation?

Menown IB.

Adv Ther. 2013 Dec;30(12):1038-40. doi: 10.1007/s12325-013-0082-8. Epub 2013 Dec 13. No abstract available.

21.

A prospective intravascular ultrasound investigation of the necessity for and efficacy of postdilation beyond nominal diameter of 3 current generation DES platforms for the percutaneous treatment of the left main coronary artery.

Shand JA, Sharma D, Hanratty C, McClelland A, Menown IB, Spence MS, Richardson G, Herity NA, Walsh SJ.

Catheter Cardiovasc Interv. 2014 Sep 1;84(3):351-8. doi: 10.1002/ccd.25265. Epub 2013 Nov 9.

PMID:
24167078
22.

An audit of outcomes after same-day discharge post-PCI in acute coronary syndrome and elective patients.

Hodkinson EC, Ramsewak A, Murphy JC, Shand JA, McClelland AJ, Menown IB, Hanratty CG, Spence MS, Walsh SJ.

J Interv Cardiol. 2013 Dec;26(6):570-7. doi: 10.1111/joic.12065. Epub 2013 Sep 30.

PMID:
24112741
23.

Very long stent technology: clinical and practical value.

Menown IB.

Future Cardiol. 2013 Sep;9(5):641-4. doi: 10.2217/fca.13.50. Review. No abstract available.

PMID:
24020665
24.

Genetic biomarkers in cardiovascular disease.

Muir AR, Menown IB.

Biomark Med. 2013 Aug;7(4):497-9. doi: 10.2217/bmm.13.82. No abstract available.

25.

The dronedarone shared-care clinical model and database: a coordinated paradigm to optimize management of evolving clinical recommendations.

Connolly M, Menown IB, Hussey S, Cinnamond N, Damani L.

Adv Ther. 2013 Jun;30(6):623-9. doi: 10.1007/s12325-013-0037-0. Epub 2013 Jun 18.

PMID:
23775593
26.

Key advances in clinical cardiology.

Connolly M, Menown IB.

Adv Ther. 2013 Apr;30(4):369-86. doi: 10.1007/s12325-013-0024-5. Epub 2013 Apr 9. Review.

PMID:
23579862
27.

Massive pulmonary embolus presenting with abdominal pain.

Hodkinson EC, Noad RL, Menown IB.

Ulster Med J. 2012 May;81(2):98. No abstract available.

28.

Resting heart rate and outcomes in patients with cardiovascular disease: where do we currently stand?

Menown IB, Davies S, Gupta S, Kalra PR, Lang CC, Morley C, Padmanabhan S.

Cardiovasc Ther. 2013 Aug;31(4):215-23. doi: 10.1111/j.1755-5922.2012.00321.x. Review.

29.

The detection of heterozygous familial hypercholesterolemia in Ireland.

O'Kane MJ, Menown IB, Graham I, Maher V, Tomkin G, Nicholls P, Graham C.

Adv Ther. 2012 May;29(5):456-63. doi: 10.1007/s12325-012-0021-0. Epub 2012 May 17.

PMID:
22610724
30.

Value of non-invasive imaging in acute chest pain.

Sharma D, Tauro R, Menown IB.

QJM. 2013 May;106(5):467-9. doi: 10.1093/qjmed/hcr196. Epub 2011 Oct 18. No abstract available.

PMID:
22008508
31.

Advances in cardiology: clinical trial update.

Howe AJ, Shand JA, Menown IB.

Future Cardiol. 2011 May;7(3):299-310. doi: 10.2217/fca.11.17. Review.

PMID:
21627472
32.

Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction: a systematic review and meta-analysis.

Shand JA, McEneaney DJ, Menown IB.

Heart. 2011 Apr;97(7):605; author reply 605. doi: 10.1136/hrt.2011.223404. No abstract available.

PMID:
21378015
33.

Ticagrelor: from concept to clinical evaluation.

Shand JA, Menown IB, Storey RF.

Biomark Med. 2011 Feb;5(1):53-62. doi: 10.2217/bmm.11.4. Review.

PMID:
21319965
34.
35.

Contemporary management of coronary heart disease.

Menown IB.

J R Coll Physicians Edinb. 2010 Mar;40(1):44-7; quiz 48. doi: 10.4997/JRCPE.2010.122. Review.

PMID:
21125040
36.

A timely diagnosis of myocardial infarction.

Shand JA, Menown IB, McEneaney DJ.

Biomark Med. 2010 Jun;4(3):385-93. doi: 10.2217/bmm.10.16. Review.

PMID:
20550472
37.

The platinum chromium element stent platform: from alloy, to design, to clinical practice.

Menown IB, Noad R, Garcia EJ, Meredith I.

Adv Ther. 2010 Mar;27(3):129-41. doi: 10.1007/s12325-010-0022-9. Epub 2010 Apr 29. Review.

PMID:
20437213
38.

Is there a Failure to Optimize theRapy in anGina pEcToris (FORGET) study?

Elder DH, Pauriah M, Lang CC, Shand J, Menown IB, Sin BD, Gupta S, Duckett SG, Foster W, Zachariah D, Kalra PR.

QJM. 2010 May;103(5):305-10. doi: 10.1093/qjmed/hcq011. Epub 2010 Feb 24.

PMID:
20181676
39.

Body surface mapping vs 12-lead electrocardiography to detect ST-elevation myocardial infarction.

Ornato JP, Menown IB, Peberdy MA, Kontos MC, Riddell JW, Higgins GL 3rd, Maynard SJ, Adgey J.

Am J Emerg Med. 2009 Sep;27(7):779-84. doi: 10.1016/j.ajem.2008.06.010.

PMID:
19683104
40.

Dyslipidemia therapy update: the importance of full lipid profile assessment.

Menown IB, Murtagh G, Maher V, Cooney MT, Graham IM, Tomkin G.

Adv Ther. 2009 Jul;26(7):711-8. doi: 10.1007/s12325-009-0052-3. Epub 2009 Jul 27. Review.

PMID:
19649582
41.

Investigation of a multimarker approach to the initial assessment of patients with acute chest pain.

McCann CJ, Glover BM, Menown IB, Moore MJ, McEneny J, Owens CG, Smith B, Sharpe PC, Young IS, Adgey JA.

Adv Ther. 2009 May;26(5):531-4. doi: 10.1007/s12325-009-0032-7. Epub 2009 May 27.

PMID:
19475367
42.

Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain.

McCann CJ, Glover BM, Menown IB, Moore MJ, McEneny J, Owens CG, Smith B, Sharpe PC, Young IS, Adgey JA.

Am J Cardiol. 2009 Jan 1;103(1):22-8. doi: 10.1016/j.amjcard.2008.08.026. Epub 2008 Oct 17.

PMID:
19101224
43.

Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T.

McCann CJ, Glover BM, Menown IB, Moore MJ, McEneny J, Owens CG, Smith B, Sharpe PC, Young IS, Adgey JA.

Eur Heart J. 2008 Dec;29(23):2843-50. doi: 10.1093/eurheartj/ehn363. Epub 2008 Aug 5.

PMID:
18682444
44.
45.

Body surface mapping: potential role in a chest pain critical care pathway.

Menown IB.

Crit Pathw Cardiol. 2003 Mar;2(1):46-51. doi: 10.1097/01.HPC.0000053681.45928.F9.

PMID:
18340318
46.

Ivabradine: a new strategy for management of stable angina.

Menown IB.

Br J Hosp Med (Lond). 2007 Jun;68(6):321-5. Review. No abstract available.

PMID:
17639836
47.

Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis.

Murphy SA, Gibson CM, Morrow DA, Van de Werf F, Menown IB, Goodman SG, Mahaffey KW, Cohen M, McCabe CH, Antman EM, Braunwald E.

Eur Heart J. 2007 Sep;28(17):2077-86. Epub 2007 Jun 28. Review.

PMID:
17600038
48.

Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.

Eikelboom JW, Quinlan DJ, Mehta SR, Turpie AG, Menown IB, Yusuf S.

Circulation. 2005 Dec 20;112(25):3855-67. Epub 2005 Dec 12.

PMID:
16344381
49.
50.

Images in cardiology: An unusual case of right ventricular dilatation.

McKeown PF, Walsh SJ, Menown IB.

Heart. 2005 Sep;91(9):1147. No abstract available.

Supplemental Content

Loading ...
Support Center